These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6782013)

  • 1. A hemolytically inactive gene product of factor B.
    Mauff G; Federmann G; Hauptmann G
    Immunobiology; 1980; 158(1-2):96-100. PubMed ID: 6782013
    [No Abstract]   [Full Text] [Related]  

  • 2. Change in serum properdin factor B phenotype following human orthoptic liver transplantation.
    Hauptmann G; Tongio MM; Klein J; Mayer S; Cinqualbre J; Jeanblanc B; Kieny R
    Immunobiology; 1980; 158(1-2):76-81. PubMed ID: 7009411
    [No Abstract]   [Full Text] [Related]  

  • 3. Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.
    Schwaeble W; Lüttig B; Sokolowski T; Estaller C; Weiss EH; Meyer zum Büschenfelde KH; Whaley K; Dippold W
    Immunobiology; 1993 Jul; 188(3):221-32. PubMed ID: 8225386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inulin-induced activation of factor B in whole serum: description of structural modifications in the Ba fragment.
    Davrinche C; Charlionet R; Rivat C; Helal AN; Lefranc G
    Eur J Immunol; 1984 Oct; 14(10):957-61. PubMed ID: 6567528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration and functional efficiency of factor B alleles.
    Mauff G; Adam R; Wachauf B; Hitzeroth HW; Hiller C
    Immunobiology; 1980; 158(1-2):86-90. PubMed ID: 6782012
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of a new BF F subtype variant by isoelectric focusing.
    Geserick G; Rose M; Martin W; Schröder H
    Exp Clin Immunogenet; 1989; 6(2):156-61. PubMed ID: 2629891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of murine complement by cobra venom factor in the presence of EDTA.
    Goldman JN; Bangalore S; Goldman MB
    J Immunol; 1979 Nov; 123(5):2421-7. PubMed ID: 114590
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo modulation of rat complement activities by infusion of anti-H antibodies.
    Veerhuis R; van Es LA; Daha MR
    Immunobiology; 1985 Sep; 170(3):133-45. PubMed ID: 2932382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of C3 and Bf allotypes in Tuscany (Italy).
    Domenici R; Giari A; Bargagna M; Weidinger S
    Hum Hered; 1986; 36(5):330-2. PubMed ID: 3639059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages.
    Falus A; Meretey K
    Immunology; 1987 Apr; 60(4):547-51. PubMed ID: 3646991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of serum proteins and levels of immunoglobulin and complement components in high caste community (Brahmins) of Madhya Pradesh, India.
    Papiha SS; Bernal JE; Mehrotra M
    Jinrui Idengaku Zasshi; 1980 Mar; 25(1):1-8. PubMed ID: 6901787
    [No Abstract]   [Full Text] [Related]  

  • 13. A new BF F variant by polyacrylamide gel isoelectric focusing.
    Nakamura S; Ohue O; Abe K
    Hum Genet; 1987 Nov; 77(3):295-6. PubMed ID: 3679216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA restriction fragment length polymorphism in the complement region of the human MHC shows an absolute correlation with polymorphism of complement factor B(Bf) defined by isoelectric focusing.
    Fathallah D; Abbal M; Thomsen M; Cambon-Thomsen A; Campbell RD
    J Immunogenet; 1985 Dec; 12(6):321-6. PubMed ID: 3016098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative pathway of human complement by haemoglobin.
    Wilson WA; Thomas EJ
    Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bf allotypes in bullous pemphigoid.
    Doutre MS; Beylot C; Abbal M; Bezian JH
    Dermatologica; 1989; 178(1):60. PubMed ID: 2645179
    [No Abstract]   [Full Text] [Related]  

  • 17. Two forms of guinea pig factor B of the alternative complement pathway with different molecular weights.
    Matsushita M; Okada H
    Mol Immunol; 1989 Jul; 26(7):669-76. PubMed ID: 2779589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative pathway of bovine complement: concentration of factor B, hemolytic activity and heritability.
    Tabel H; Menger M; Aston WP; Cochran M
    Vet Immunol Immunopathol; 1984 Mar; 5(4):389-98. PubMed ID: 6428035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the alternative pathway of bovine complement by Trypanosoma congolense.
    Tabel H
    Parasite Immunol; 1982 Sep; 4(5):329-35. PubMed ID: 7145463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.